DEXCO INC
DEXCO INC
Share · US2521311074 · DXCM · A0D9T1 (XNAS)
Overview Financial Indicators
86,67 USD
1,04 % 0,89 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:04

Current Prices from DEXCO INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DXCM
USD
06.06.2025 20:04
86,67 USD
85,74 USD
+1,08 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 1,01 % 6,30 % 8,70 % 11,52 % -24,83 % -4,88 %

Company Profile for DEXCO INC Share

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Invested Funds

The following funds have invested in: DEXCO INC invested:

Fund
iShares US Medical Devices UCITS ETF USD (Acc)
Vol. in million
1.624,62
Percentage (%)
2,91 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
2.400,41
Percentage (%)
0,66 %
Fund
iShares Nasdaq 100 UCITS ETF EUR Hedged (Acc)
Vol. in million
657,26
Percentage (%)
0,35 %
Fund
iShares NASDAQ-100® UCITS ETF (DE)
Vol. in million
11.742,50
Percentage (%)
0,35 %
Fund
iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
1.858,42
Percentage (%)
0,17 %

Company Data

Name DEXCO INC
Company DexCom, Inc.
Symbol DXCM
Website https://www.dexcom.com
Primary Exchange XNAS NASDAQ
WKN A0D9T1
ISIN US2521311074
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Mr. Kevin Ronald Sayer
Market Capitalization 27 Mrd.
Country United States of America
Currency USD
Employees 10,2 T
Address 6340 Sequence Drive, 92121 San Diego
IPO Date 2005-04-14

Stock Splits

Date Split
13.06.2022 4:1

Ticker Symbols

Name Symbol
Frankfurt DC4.F
NASDAQ DXCM
XETRA DC4.DE

More Shares

Investors who DEXCO INC hold also have the following shares in their portfolio:
.FIN.HL. 19/27
.FIN.HL. 19/27 Bond
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
CINTAS CORP
CINTAS CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
FASTENAL CO
FASTENAL CO Share
INTEL CORP
INTEL CORP Share
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Share
LOUIS. PAC. CORP
LOUIS. PAC. CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
QNB FINANCE LIMITED 1.625% NTS 22/09/25
QNB FINANCE LIMITED 1.625% NTS 22/09/25 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
XTR.M.W.E.U.E. 1CDLA
XTR.M.W.E.U.E. 1CDLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025